Todralazine

HCID 5501CAS 14679-73-3

Basic information

Standard SMILES
CCOC(=O)NNc1nncc2ccccc12
InChIKey
WGZDBVOTUVNQFP-UHFFFAOYSA-N
Molecular formula
C11H12N4O2
Average molar mass
232.24 g/mol
Monoisotopic mass
232.09602564

Names & identifiers

Preferred name
Todralazine
IUPAC
ethyl N-(phthalazin-1-ylamino)carbamate
English name
Todralazine
Molecular formula
C11H12N4O2
Molecular weight
232.242

Names & synonyms

todralazine14679-73-3EcarazineEthyl 3-(1-phthalazinyl)carbazateCEPH FREE BASEWEN3K83YKDBT-621 FREE BASENSC-757868DTXSID0045048TodrazolineHydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochlorideRefChem:190269
Show more names
BT-6213-(1-Phthalazinyl)carbazic acid ethyl2-(1-phthalazinyl)Hydrazinecarboxylic acid ethyl esterHydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester
DTXCID8025048TodralazinaTodralacinaCarboethoxyphthalazinohydrazine3-(1-Phthalazinyl)carbazic acid ethyl esterBT 621CARBAZIC ACID, 3-(1-PHTHALAZINYL)-, ETHYL ESTERCEPH

Database identifiers

CAS
14679-73-3
PubChem CID
5501
DTXSID
DTXSID0045048
ChEMBL
CHEMBL1079787
ChEBI
CHEBI:94706
UNII
WEN3K83YKD
Nikkaji
J9.606G

Properties

Computed structural properties

XLogP
1.7
Topological polar surface area
76.1 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
4
Heavy atoms
17

Experimental & physicochemical properties

Collision Cross Section · 2 items

151.8 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664];152.0 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664];158.8 Ų [M+Na]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664]

141.14 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];149.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];156.68 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];155.49 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Boiling point
374.4 °C · 374.4°C (rough estimate)
Density
1.2295 · 1.2295 (rough estimate)
refractive index
1.6 · 1.6000 (estimate)
storage temp.
-20 °C · Store at -20°C
solubility
DMSO (Slightly)
pka
8.82 · 8.82±0.43(Predicted)

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Applications

UsesTodralazine hemi-oxolate salt is an antihypertensive agent for research use. Vasodilator.

Suppliers9 total

MedChemexpress LLC021-58955995 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
Musechem+1-800-259-7612 · [email protected]

Additional notes

DefinitionChEBI: N-(1-phthalazinylamino)carbamic acid ethyl ester is a member of phthalazines.

Related reactions

1 records

Linked notes

Loading…